Science Strategic Acquisition Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Science Strategic are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Science Strategic Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Science Strategic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 20 K | |
| Total Cashflows From Investing Activities | -310.5 M | |
| Free Cash Flow | -1.3 B |
Science |
Science Strategic Relative Risk vs. Return Landscape
If you would invest (100.00) in Science Strategic Acquisition on October 21, 2025 and sell it today you would earn a total of 100.00 from holding Science Strategic Acquisition or generate -100.0% return on investment over 90 days. Science Strategic Acquisition is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Science, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Science Strategic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Science Strategic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Science Strategic Acquisition, and traders can use it to determine the average amount a Science Strategic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SSAA |
Based on monthly moving average Science Strategic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Science Strategic by adding Science Strategic to a well-diversified portfolio.
Science Strategic Fundamentals Growth
Science Stock prices reflect investors' perceptions of the future prospects and financial health of Science Strategic, and Science Strategic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Science Stock performance.
| Return On Asset | -0.0118 | |||
| Current Valuation | 390.76 M | |||
| Shares Outstanding | 31.05 M | |||
| Price To Earning | 19.10 X | |||
| Price To Book | 1.31 X | |||
| EBITDA | 158.78 M | |||
| Cash And Equivalents | 511.76 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 750 K | |||
| Book Value Per Share | (0.32) X | |||
| Cash Flow From Operations | (1.33 B) | |||
| Earnings Per Share | 0.40 X | |||
| Total Asset | 311.26 M | |||
Things to note about Science Strategic performance evaluation
Checking the ongoing alerts about Science Strategic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Science Strategic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Science Strategic is not yet fully synchronised with the market data | |
| Science Strategic has some characteristics of a very speculative penny stock | |
| Science Strategic has a very high chance of going through financial distress in the upcoming years | |
| Science Strategic Acquisition currently holds 750 K in liabilities. Science Strategic has a current ratio of 0.31, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Science Strategic's use of debt, we should always consider it together with its cash and equity. | |
| Science Strategic Acquisition currently holds about 511.76 K in cash with (1.33 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Over 92.0% of the company shares are owned by institutional investors |
- Analyzing Science Strategic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Science Strategic's stock is overvalued or undervalued compared to its peers.
- Examining Science Strategic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Science Strategic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Science Strategic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Science Strategic's stock. These opinions can provide insight into Science Strategic's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Science Stock
If you are still planning to invest in Science Strategic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science Strategic's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |